Clinical Trials Browser

INDUSTRY × leronlimab × Gastrointestinal × Clear all

NCT06699836 2025-10-02

A Phase 2 Study of Leronlimab in Combination With TAS-102 + Bevacizumab in Previously Treated Participants With mCRC

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms